179 related articles for article (PubMed ID: 27089107)
1. Utilization of fecal occult blood test in the acute hospital setting and its impact on clinical management and outcomes.
Mosadeghi S; Ren H; Catungal J; Yen I; Liu B; Wong RJ; Bhuket T
J Postgrad Med; 2016; 62(2):91-5. PubMed ID: 27089107
[TBL] [Abstract][Full Text] [Related]
2. Fecal occult blood testing as a diagnostic test in symptomatic patients is not useful: a retrospective chart review.
Narula N; Ulic D; Al-Dabbagh R; Ibrahim A; Mansour M; Balion C; Marshall JK
Can J Gastroenterol Hepatol; 2014 Sep; 28(8):421-6. PubMed ID: 25014182
[TBL] [Abstract][Full Text] [Related]
3. Use of fecal occult blood testing in hospitalized patients: results of an audit.
Ip S; Sokoro AA; Kaita L; Ruiz C; McIntyre E; Singh H
Can J Gastroenterol Hepatol; 2014 Oct; 28(9):489-94. PubMed ID: 25314355
[TBL] [Abstract][Full Text] [Related]
4. Use and abuse of fecal occult blood tests: a community hospital experience.
Soin S; Akanbi O; Ahmed A; Kim Y; Pandit S; Wroblewski I; Saleem N
BMC Gastroenterol; 2019 Sep; 19(1):161. PubMed ID: 31481027
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of colorectal diseases in immunological fecal occult blood test (I-FOBT) positive patients in a tertiary care hospital in Bangladesh.
Mollick SH; Roy PK; Bhuiyan MR; Mia AR; Alam MS; Mollick KA; Pervin S; Hassan MQ
Mymensingh Med J; 2014 Oct; 23(4):764-9. PubMed ID: 25481598
[TBL] [Abstract][Full Text] [Related]
6. A closer look at same-day bidirectional endoscopy.
Urquhart J; Eisen G; Faigel DO; Mattek N; Holub J; Lieberman DA
Gastrointest Endosc; 2009 Feb; 69(2):271-7. PubMed ID: 18725159
[TBL] [Abstract][Full Text] [Related]
7. Clinical utilization of digital rectal examination and fecal occult blood testing upon hospital admission.
Scales CD; Fein S; Muir AJ; Rockey DC
J Clin Gastroenterol; 2006; 40(10):913-8. PubMed ID: 17063111
[TBL] [Abstract][Full Text] [Related]
8. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
Quintero E
Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
[TBL] [Abstract][Full Text] [Related]
9. Impact of fecal occult blood on obscure gastrointestinal bleeding: observational study.
Kobayashi Y; Watabe H; Yamada A; Suzuki H; Hirata Y; Yamaji Y; Yoshida H; Koike K
World J Gastroenterol; 2015 Jan; 21(1):326-32. PubMed ID: 25574108
[TBL] [Abstract][Full Text] [Related]
10. Use of Fecal Occult Blood Testing as a Diagnostic Tool for Clinical Indications: A Systematic Review and Meta-Analysis.
Lee MW; Pourmorady JS; Laine L
Am J Gastroenterol; 2020 May; 115(5):662-670. PubMed ID: 31972617
[TBL] [Abstract][Full Text] [Related]
11. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
[TBL] [Abstract][Full Text] [Related]
12. Use of lower gastrointestinal endoscopy and fecal occult blood test in the 2007 Swiss Health Interview Survey respondents aged 50 years and older.
Spaeth A; Zwahlen M
Endoscopy; 2013 Jul; 45(7):560-6. PubMed ID: 23780844
[TBL] [Abstract][Full Text] [Related]
13. Challenges in the management of positive fecal occult blood tests.
Rao SK; Schilling TF; Sequist TD
J Gen Intern Med; 2009 Mar; 24(3):356-60. PubMed ID: 19130147
[TBL] [Abstract][Full Text] [Related]
14. Inappropriate use of the faecal occult blood test outside of the National Health Service colorectal cancer screening programme.
Peacock O; Watts ES; Hanna N; Kerr K; Goddard AF; Lund JN
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1270-5. PubMed ID: 22872076
[TBL] [Abstract][Full Text] [Related]
15. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
[TBL] [Abstract][Full Text] [Related]
16. Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE).
Stock C; Brenner H
Endoscopy; 2010 Jul; 42(7):546-56. PubMed ID: 20432204
[TBL] [Abstract][Full Text] [Related]
17. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
[TBL] [Abstract][Full Text] [Related]
18. [Early detection of bowel cancer in occupational surveillance examinations: switching from a guaiak-based to an immunochemical fecal occult blood test].
Webendörfer S; Riemann JF
Dtsch Med Wochenschr; 2014 Jan; 139(3):79-83. PubMed ID: 24089288
[TBL] [Abstract][Full Text] [Related]
19. Better acceptance of Fecal Occult Blood Test (FOBT) for colorectal cancer screening during hospitalization.
Keller R; Schätzle A; Flieger D; Christl SU; Fischbach W
Z Gastroenterol; 2003 Jul; 41(7):655-8. PubMed ID: 12858236
[TBL] [Abstract][Full Text] [Related]
20. Use and abuse of faecal occult blood tests in an acute hospital inpatient setting.
Friedman A; Chan A; Chin LC; Deen A; Hammerschlag G; Lee M; Liddell J; Loh K; Moore E; Ng J; Gibson PR
Intern Med J; 2010 Feb; 40(2):107-11. PubMed ID: 20021507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
